P450 Pharmacogenetics in Indigenous North American Populations
AbstractIndigenous North American populations, including American Indian and Alaska Native peoples in the United States, the First Nations, Métis and Inuit peoples in Canada and Amerindians in Mexico, are historically under-represented in biomedical research, including genomic research on drug disposition and response. Without adequate representation in pharmacogenetic studies establishing genotype-phenotype relationships, Indigenous populations may not benefit fully from new innovations in precision medicine testing to tailor and improve the safety and efficacy of drug treatment, resulting in health care disparities. The purpose of this review is to summarize and evaluate what is currently known about cytochrome P450 genetic variation in Indigenous populations in North America and to highlight the importance of including these groups in future pharmacogenetic studies for implementation of personalized drug therapy. View Full-Text
Share & Cite This Article
Henderson, L.M.; Claw, K.G.; Woodahl, E.L.; Robinson, R.F.; Boyer, B.B.; Burke, W.; Thummel, K.E. P450 Pharmacogenetics in Indigenous North American Populations. J. Pers. Med. 2018, 8, 9.
Henderson LM, Claw KG, Woodahl EL, Robinson RF, Boyer BB, Burke W, Thummel KE. P450 Pharmacogenetics in Indigenous North American Populations. Journal of Personalized Medicine. 2018; 8(1):9.Chicago/Turabian Style
Henderson, Lindsay M.; Claw, Katrina G.; Woodahl, Erica L.; Robinson, Renee F.; Boyer, Bert B.; Burke, Wylie; Thummel, Kenneth E. 2018. "P450 Pharmacogenetics in Indigenous North American Populations." J. Pers. Med. 8, no. 1: 9.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.